InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Rogers Campbell, Chief Medical Officer. Officer active across 3 companies, notably Heartflow, Inc.. In total, 14 filings have been logged. Split: 0 buy · 2 sells. Total volume traded: €535k. Activity tracked since 13 October 2021. The latest transaction was disclosed on 17 August 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Rogers Campbell
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
9,219 shares@ US$19.000.0045% mcap11.4% of flowCommon StockSEC:0001464521-26-000135:0
9,219 shares@ US$41.230.0097% mcap24.8% of flowCommon StockSEC:0001464521-26-000135:1
1,635 shares@ US$27.190.0018% mcap7.5% of flowCommon StockSEC:0001464521-26-000119:0
637 shares@ US$28.820.0007% mcap3.1% of flowCommon StockSEC:0001464521-26-000119:1
9,219 shares@ US$19.000.0075% mcap22.9% of flowCommon StockSEC:0001464521-26-000103:0
9,219 shares@ US$25.720.010% mcap31.0% of flowCommon StockSEC:0001464521-26-000103:1
291 shares@ US$8.330.0001% mcap1.4% of flowCommon StockSEC:0001464521-26-000052:0
19,402 shares@ US$2.220.0015% mcap24.7% of flowCommon StockSEC:0001464521-26-000048:0
19,401 shares@ US$2.220.0015% mcap23.9% of flowCommon StockSEC:0001464521-26-000018:0
515 shares@ US$27.7412.1% of flowCommon StockSEC:0001464521-26-000012:0
439 shares@ US$32.5614.0% of flowCommon StockSEC:0001464521-25-000033:0
21,052 shares0Common StockSEC:0001628280-25-039733:0
17,248 shares0Common StockSEC:0001493152-21-025451:0
1 sharesCommon StockSEC:0001615774-16-004030:0
14 of 14 declarations
About Rogers Campbell
Rogers Campbell is Chief Medical Officer at Heartflow, Inc. and Director at InspireMD, Inc. He has 10 filings in total, and across the sampled recent filings spanning 2016-01-28 to 2026-07-17, sales amount to EUR 207284 and the most frequent transaction nature is option exercise.
